Earnings History Data for Neuropace, Inc. (NPCE) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Neuropace, Inc.
NeuroPace Inc. is a commercial-stage medical device company. It is focused on developing products to treat and transform the lives of patients suffering from epilepsy. NeuroPace Inc. is based in MOUNTAIN VIEW, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | AH | NPCE | Neuropace, Inc. | 219.27 | -0.19 | -0.26 | -0.28 | NeuroPace GAAP EPS of -$0.19 beats by $0.08, revenue of $21.1M beats by $2.02M [11/12/2024 4:19 PM] |
9.01 | 1.87 (26.19%) |
7.14 | 0.0 (0.00%) |
5.45 - 18.15 | 352,957 | 60,000 | 5,638 | ||
| 13-08-2024 | AH | NPCE | NeuroPace | 205.00 | -0.26 | -0.29 | 0.00 | NeuroPace GAAP EPS of -$0.26 beats by $0.05, revenue of $19.3M beats by $1M [8/13/2024 4:23 PM] |
6.72 | -0.56 (-7.62%) |
7.40 | 0.12 (1.64%) |
4.21 - 18.15 | 595,253 | 40,000 | 4,964 | ||
| 08-05-2024 | AH | NPCE | Neuropace, Inc. | 381.80 | -0.32 | -0.32 | -0.41 | NeuroPace GAAP EPS of -$0.32 [5/8/2024 4:28 PM] |
8.00 | -4.60 (-36.51%) |
0.0 | 0.0 (0.00%) |
3.80 - 18.15 | 418,656 | 80,000 | 0 | ||
| 05-03-2024 | AH | NPCE | NeuroPace | 425.00 | -0.23 | -0.33 | 0.00 | NeuroPace GAAP EPS of -$0.23 [3/6/2024 1:11 PM] |
14.04 | -0.15 (-1.09%) |
12.51 | -1.69 (-11.90%) |
3.18 - 18.15 | 411,900 | 100,000 | 3,470 | ||
| 06-11-2023 | AH | NPCE | Neuropace, Inc. | 181.02 | -0.28 | -0.39 | -0.48 | NeuroPace GAAP EPS of -$0.28 beats by $0.13, revenue of $16.4M beats by $2.18M [11/6/2023 4:36 PM] |
7.25 | 0.05 (0.69%) |
6.88 | -0.32 (-4.44%) |
1.22 - 9.73 | 76,846 | 50,000 | 584 | ||
| 08-08-2023 | AH | NPCE | Neuropace, Inc. | 105.43 | -0.36 | -0.47 | -0.52 | NeuroPace GAAP EPS of -$0.36 beats by $0.11, revenue of $16.5M beats by $3.87M [8/8/2023 4:21 PM] |
4.50 | 0.40 (9.76%) |
4.60 | 0.50 (12.20%) |
1.22 - 6.45 | 570,750 | 0 | 924 | ||
| 04-05-2023 | AH | 4:00 PM ET (May 4) |
NPCE | Neuropace, Inc. | 123.99 | -0.41 | -0.46 | -0.47 | NeuroPace GAAP EPS of -$0.41 beats by $0.04, revenue of $14.5M beats by $2.33M [5/4/2023 5:12 PM] |
5.05 | 0.06 (1.20%) |
0.0 | 0.0 (0.00%) |
1.22 - 7.18 | 64,515 | 20,000 | 0 | |
| 02-03-2023 | AH | 4:00 PM ET (Mar 2) |
NPCE | Neuropace, Inc. | 118.29 | -0.45 | -0.49 | -0.44 | NeuroPace reports Q4 results, co guides FY 2023 revenue above consensus [3/2/2023 4:08 PM] |
3.90 | -0.30 (-7.14%) |
4.40 | 0.20 (4.76%) |
1.22 - 9.54 | 143,257 | 30,000 | 310 | |
| 08-11-2022 | AH | 4:00 PM ET (Nov 8) |
NPCE | Neuropace, Inc. | 58.64 | -0.48 | -0.52 | -0.34 | NeuroPace GAAP EPS of -$0.48 beats by $0.06, revenue of $11.2M beats by $1.31M [11/8/2022 4:12 PM] |
2.19 | -0.34 (-13.44%) |
0.0 | 0.0 (0.00%) |
2.12 - 17.27 | 53,836 | 10,000 | 0 | |
| 11-08-2022 | AH | 4:00 PM ET (Aug 11) |
NPCE | Neuropace, Inc. | 136.56 | -0.52 | -0.44 | -0.36 | NeuroPace GAAP EPS of -$0.52 misses by $0.07, revenue of $10.2M misses by $0.88M [8/11/2022 4:05 PM] |
5.43 | -0.45 (-7.72%) |
6.14 | 0.25 (4.24%) |
4.61 - 24.65 | 29,728 | 20,000 | 300 | |
| 12-05-2022 | AH | 4:00 PM ET (May 12) |
NPCE | Neuropace, Inc. | 151.76 | -0.47 | -0.46 | -21.21 | NeuroPace GAAP EPS of -$0.47 misses by $0.04, revenue of $11.4M beats by $0.64M [5/12/2022 4:07 PM] |
6.13 | -0.13 (-2.08%) |
6.26 | 0.0 (0.00%) |
5.59 - 26.28 | 66,239 | 70,000 | 246 | |
|
||||||||||||||||||
| 10-03-2022 | AH | 4:00 PM ET (Mar 10) |
NPCE | Neuropace, Inc. | 196.94 | -0.44 | -0.33 | 0.00 | NeuroPace GAAP EPS of -$0.44 misses by $0.10, revenue of $11M misses by $0.02M [3/10/2022 4:10 PM] |
7.96 | 0.35 (4.53%) |
8.55 | 0.40 (4.91%) |
6.75 - 27.38 | 80,094 | 50,000 | 0 | |
| 10-11-2021 | AH | 4:00 PM ET (Nov 10) |
NPCE | Neuropace, Inc. | 421.78 | -0.34 | -0.30 | 0.00 | NeuroPace EPS misses by $0.04, misses on revenue [11/10/2021 4:07 PM] |
13.89 | -1.91 (-12.09%) |
15.80 | 0.0 (0.00%) |
12.00 - 27.38 | 173,856 | 50,000 | 100 | |
|
||||||||||||||||||
| 12-08-2021 | AH | After the close (Aug 12) |
NPCE | Neuropace, Inc. | 580.32 | -0.36 | -0.39 | 0.00 | 20.40 | -1.26 (-5.82%) |
21.66 | 0.0 (0.00%) |
18.24 - 27.38 | 170,143 | 20,000 | 534 | ||
| 03-06-2021 | PM | Before the open (Jun 3) |
NPCE | Neuropace, Inc. | 546.38 | -21.21 | -0.25 | 0.00 | NeuroPace EPS misses by $32.45, beats on revenue; issues guidance [6/3/2021 7:21 AM] |
21.44 | -1.05 (-4.67%) |
22.85 | 0.36 (1.60%) |
18.24 - 27.38 | 80,779 | 80,000 | 241 | |